iFast Diagnostics: Funding, Investors & Team (Oct 2026)
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance.
iFast Diagnostics has raised $3.9M across 1 funding round on record, the most recent a Seed of $3.9M announced in May 2026.
That round is below the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.
iFast Diagnostics Company Profile and Key Stats
Latest funding round on record: May 2026.
iFast Diagnostics Funding Rounds
iFast Diagnostics Founders and Leadership Team
Contact details for the iFast Diagnostics team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →iFast Diagnostics Funding Compared to Other Health Care Startups
iFast Diagnostics' latest round of $3.9M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like iFast Diagnostics in Health Care and Northampton
Companies Similar to iFast Diagnostics
52 North Health intends to further develop medical services with a clinical gadget that utilizes man-made…
SageTech is recycling inhalational anaesthetic agents using patented technology to generate significant cost…
Renata Medical develops purposeful medical devices for unmet pediatric needs.
Leo Cancer Care provides a streamlined and effective treatment method that empowers patients and instills…
Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous…
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
Nebu-Flow is a manufacturer of the next generation of inhaled drugs for patients with respiratory disorders.…
Innovative medical gadgets are created by Creo Medical Limited, situated in Chepstow, South Wales. With a…
TympaHealth has developed the world's first ear and hearing health assessment system. The Tympa system…
NEX Health Intelligence (NEX) is a health-tech business that develops AI-powered software for hospitals to…
Infex Therapeutics acquire, develop and license drugs to treat pandemic infections.
Asterix Health is the workforce solution for modern healthcare.
iFast Diagnostics Funding FAQs
What does iFast Diagnostics do?
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance.
How much funding has iFast Diagnostics raised?
iFast Diagnostics has raised $3.9M across 1 round on record. The most recent is a Seed of $3.9M announced in May 2026.
When did iFast Diagnostics last raise funding?
iFast Diagnostics' most recent funding round on record is a Seed of $3.9M, announced in May 2026.
Who founded iFast Diagnostics?
FundedIQ lists Toby King (Founder) at iFast Diagnostics.
Where is iFast Diagnostics headquartered?
iFast Diagnostics is based in Northampton, Northamptonshire, United Kingdom.
How many employees does iFast Diagnostics have?
iFast Diagnostics is in the 11-50 employee band.
How does iFast Diagnostics' funding compare to other Health Care startups?
iFast Diagnostics' latest round of $3.9M is below the $4.8M median round size for Health Care companies on FundedIQ across 3,657 tracked companies over the last two years.
About FundedIQ's iFast Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for iFast Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.